COMMUNIQUÉS West-GlobeNewswire

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease
16/09/2026
The First and Only Anti-Amyloid Treatment in Japan that Enable At-Home Administration for Alzheimer's Disease, a Progressive Disease TOKYO and CAMBRIDGE, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. and [...]
MESSAGE DU CEO DE TME PHARMA
16/09/2026
MESSAGE DU CEO DE TME PHARMA Berlin, Allemagne, le 16 septembre 2026, 8 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de biotechnologie au stade clinique spécialisée dans le développement de [...]
TME PHARMA CEO MESSAGE
16/09/2026
TME PHARMA CEO MESSAGE Berlin, Germany, September 16, 2026, 8.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for [...]
First Patient In - BioPorto Initiates Patient Enrollment as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
16/09/2026
September 16, 2026 News Release First Patient In - BioPorto Initiates Patient Enrollment as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study. COPENHAGEN, DENMARK, September 16 , 2026 – BioPorto A/S (“ [...]
EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)
16/09/2026
Late Breaking Oral Presentation at 26th EURETINA Congress, 1-4 October 2026, Vienna PARIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing [...]
Novo to share real-world and clinical data including Wegovy® pill, and cardiometabolic pipeline progress with next-generation amylin treatments at EASD 2026
16/09/2026
New data will highlight the breadth of semaglutide evidence across the cardiometabolic spectrum, including obesity, type 2 diabetes, cardiovascular, kidney and fatty liver disease, and new data on Wegovy® pill, Wegovy® [...]
UpFront Diagnostics obtient le marquage CE pour LVOne, premier test sanguin rapide au monde destiné au diagnostic de l’AVC
16/09/2026
LVOne est le seul kit de diagnostic sanguin destiné au diagnostic de l’AVC à avoir obtenu le marquage CE CAMBRIDGE, Royaume-Uni, 16 sept. 2026 (GLOBE NEWSWIRE) -- UpFront Diagnostics annonce l’obtention du marquage CE [...]
UpFront Diagnostics Announces CE Mark Approval for LVOne — the World's First Rapid Blood Test to Diagnose Stroke
16/09/2026
LVOne is the only blood-based diagnostics kit for stroke diagnosis to be CE certified CAMBRIDGE, United Kingdom, Sept. 16, 2026 (GLOBE NEWSWIRE) -- UpFront Diagnostics has announced CE mark approval for LVOne—the world' [...]
EIB and Angelini Ventures’ Partnership Reaches €48.5 Million in Investments
16/09/2026
Rome, 16 September 2026 New €17 million investment into MMI, a microsurgery robotics company, marks the third investment completed under the €150 million partnership in less than 12 months, following ADCytherix and [...]
Theolytics to Showcase its Innovative Oncolytic Immunotherapy Strategy – including THEO-260 in Advanced Ovarian Cancer – at Upcoming Investor and Scientific Events
16/09/2026
Oxford, UK, September 16, 2026 – Theolytics, a clinical-stage biotechnology company developing next-generation oncolytic immunotherapies, today announced that members of its senior leadership team will participate in a [...]
Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
16/09/2026
IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the pricing of an underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17 [...]
Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye Disease
16/09/2026
Strategic shareholders commit A$7.1 million at a premium to market, the Company’s fourth consecutive equity raise priced at a premium, alongside A$3.75 million of non-dilutive R&D Tax Incentive pre-financing SYDNEY [...]
Nicox : Les données sur NCX 470 seront présentées lors du Congrès annuel 2026 de l’AAOpt
16/09/2026
Communiqué de presse Nicox : Les données sur NCX 470 seront présentées lors du Congrès annuel 2026 de l’AAOpt 16 septembre 2026 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : [...]
Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026
16/09/2026
Press Release Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026 September 16, 2026 – release at 7:30 am Sophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international [...]
Ford must answer for poor hospital privatization track record over last five years
15/09/2026
New report tracks town-by-town how the privatization scheme has created new inequalities, delays, higher costs and wasted local public hospitals’ resources TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- In the Ford [...]
Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting
15/09/2026
New product offerings extend bunion market leadership and accelerate penetration into new foot & ankle market adjacencies PONTE VEDRA, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace [...]
Greenhouse Treatment Center Strengthens Care Team with Three New Leadership Appointments
16/09/2026
GRAND PRAIRIE, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center, a leading addiction treatment facility in Grand Prairie, Texas, has welcomed three new experienced clinical and medical leaders to [...]
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
16/09/2026
CARLSBAD, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” ), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today filed a patent [...]
Keystone Behavioral Health Releases Substance Use Treatment FAQ for York County Patients and Families
16/09/2026
York County provider addresses frequently asked questions about medication-assisted treatment, detox, levels of care and the cost of treatment Rock Hill, SC, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Keystone Behavioral Health [...]

Pages